| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2001030768A9 Methods and compositions utilizing quinazolinones |
| 08/15/2002 | US20020111385 Synergistic mixtures |
| 08/15/2002 | US20020111364 ABCA-1 elevating compounds |
| 08/15/2002 | US20020111360 Quinazoline formulations and therapeutic use thereof |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111273 Insecticides, fungicides, miticides, plant safening agents |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/14/2002 | EP1230225A2 Pharmaceutically active 4-substituted pyrimidine derivatives |
| 08/14/2002 | EP1230224A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 08/14/2002 | EP0535034B1 Pharmaceutically active benzoquinazoline compounds |
| 08/14/2002 | DE10106420A1 Selektive Herbizide auf Basis von substituierten Arylketonen und Safenern Selective herbicides based on substituted aryl ketones and safeners |
| 08/14/2002 | CN1364156A Novel naphthalene ureas as glucose uptake enhancers |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1089090C Preparation method of 6,7-dimethoxy-2,4-(1H,3H)-quinazoline diketon |
| 08/13/2002 | US6433185 N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/13/2002 | US6433170 Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-yl)amino]- cyclopent-2-enylmethanols |
| 08/13/2002 | US6432963 Antiinflammatory agents; tyrosine kinase inhibitor |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432879 Substituted phenyl uracils |
| 08/13/2002 | CA2101952C Sulfonylurea derivatives, their preparation and their use |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002060880A1 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| 08/08/2002 | WO2002060874A1 Potassium channel inhibitors |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060450A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | WO2002060400A1 Novels couplers for use in oxidative hair dyeing |
| 08/08/2002 | WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 08/08/2002 | WO2002007729A9 Non-sedating barbiturate compounds as neuroprotective agents |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties |
| 08/08/2002 | WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 08/08/2002 | WO2001056555A3 Use of cox-2 inhibitors for the treatment of constipation |
| 08/08/2002 | US20020107393 The crystalline monohydrate form provides increased stability over the anhydrous form. |
| 08/08/2002 | DE10164513A1 Verfahren zur kontinuierlichen biotechnologischen Herstellung von kompatiblen Soluten aus toxischen Substraten Process for the continuous biotechnological production of compatible solutes from toxic substrates |
| 08/08/2002 | CA2672805A1 Pyrimidine derivatives |
| 08/08/2002 | CA2436958A1 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| 08/08/2002 | CA2435958A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | CA2432783A1 Potassium channel inhibitors |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229025A1 Novel quinazoline derivatives |
| 08/07/2002 | EP1229024A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRIN ALPHA-V BETA-3 ANTAGONISM |
| 08/07/2002 | EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 08/07/2002 | EP1228047A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 08/07/2002 | EP1228043A1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 08/07/2002 | EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1136472A4 Aryl- and heteroarylamides of carboalkoxysulfanilic acids |
| 08/07/2002 | EP0638112B1 Liquid crystal compounds having perfluoroether terminal portions |
| 08/07/2002 | CN1362951A Dihetero-substituted metalloprotease inhibitors |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362409A 2-phenoxy pyrimidine derivative and its use in treating disease |
| 08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/06/2002 | US6429328 Processes and intermediate compounds for preparing guanidine and amidine derivatives |
| 08/06/2002 | US6429311 Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof |
| 08/06/2002 | US6429214 Inhibitors of bone resorption |
| 08/01/2002 | WO2002059110A1 Pyrimidineamines as angiogenesis modulators |
| 08/01/2002 | WO2002059083A2 Novel compounds |
| 08/01/2002 | WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002028841A3 Reagents for labeling biomolecules having aldehyde or ketone moieties |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103216 6-substituted pyrimidine 3-oxides for promoting pigmentation of the skin/hair |
| 08/01/2002 | US20020103215 Beta-aryl-alpha-oxysubstituted alkylcarboxylic acids; antiobesity and hypocholesterolemic compounds |
| 08/01/2002 | US20020103213 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis |
| 08/01/2002 | US20020103205 Muscarinic antagonists |
| 08/01/2002 | US20020103198 Acylamino cyclopropane derivatives |
| 08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1226138A1 Fab i inhibitors |
| 07/31/2002 | EP1226129A1 Methods and compositions utilizing quinazolinones |
| 07/31/2002 | EP1226128A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/31/2002 | EP1226127A2 Uracil substituted phenyl sulfamoyl carboxamides |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1225874A1 Antiviral compositions |
| 07/31/2002 | EP0944565B1 1,3,5-trifluoronaphthalene derivatives for liquid crystalline mixtures |
| 07/31/2002 | EP0719267B1 Second messenger cell signaling inhibitors |
| 07/31/2002 | CN1361767A 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 07/31/2002 | CN1361766A Tricyclic compounds bearing acyloxymethoxy-carbonyl pendants |
| 07/31/2002 | CN1361687A Phosphate transport inhibitors |
| 07/31/2002 | CN1361103A 2,6-dipirimioxy benzoxy quaternary ammonium salt compound |
| 07/31/2002 | CN1088453C Fluorine-substituted liquid-crystal compound, liquid-crystal composition and liquid-crystal display device |
| 07/30/2002 | US6426415 Polyadenosine 5'-diphospho-ribose polymerase (parp) enzyme inhibitors, alkoxy substituted n-heterocycle derivatives |
| 07/30/2002 | US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia |
| 07/30/2002 | US6426348 For therapy of inflammation associated with chronic inflammatory diseases such as rheumatoid arthritis (ra), multiple sclerosis, (ms), asthma, and inflammatory bowel disease (i bd) |
| 07/25/2002 | WO2002057239A2 Pyrimidine phosphorylase as a target for imaging and therapy |